Dr. Jeong Ho Lee, Korea Advanced Institute of Science and Technology, Republic of Korea

Symposia: Primary cilia in normal and pathological conditions

Yukiko Gotoh

Dr. Jeong Ho Lee joined KAIST at 2012 as a faculty and he has proposed and validated a novel concept of ‘brain somatic mutations’ as a new entity of genetic causes for various incurable human brain disorders. Dr. Lee and his lab have shown that low-level somatic mutations in a focal brain region actually contribute to several incurable brain disorders with previously unknown etiology, such as intractable epilepsy, autism spectrum disorder, schizophrenia, brain tumors, and Alzheimer’s disease. (Lee et al, Nat Genet 2012; Lim et al, Nat Med 2015; Lim et al, Am J Hum Genet 2017; Park et al, Neuron 2018; Lee et al, Nature 2018; Koh et al, Nat Med 2018; Park et al, Nat Commun 2019; Kim et al, J Clin Invest 2019; Sim et al, Acta Neuropathol 2019; Kim et al, Ann Neurol 2021; Koh et al, Ann Neurol 2021; Kim et al, Biol Psychiatry 2021).

Dr. Lee has been recognized by numerous awards, including the Innovators in Science Award of The New York Academy of Science & Takeda 2020, the Kyung-Am award of the Kyung-Am Foundation 2020, and the KAISTian of the Year in 2018.


« Go Back

Supporting Publication
Organised by
  • Elsevier
  • ISDN